References
Dikic I. Proteasomal and autophagic degradation systems. Annu Rev Biochem 2017, 86: 193–224.
Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 2019, 366: 818–822.
Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov 2018, 17: 660–688.
Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell 2023, 186: 693–714.
Hung ST, Linares GR, Chang WH, Eoh Y, Krishnan G, Mendonca S, et al. PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. Cell 2023, 186: 786-802.e28.
van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet 2017, 390: 2084–2098.
Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature 2016, 539: 197–206.
Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med 2018, 24: 313–325.
Shisheva A. PIKfyve: partners, significance, debates and paradoxes. Cell Biol Int 2008, 32: 591–604.
Posor Y, Jang W, Haucke V. Phosphoinositides as membrane organizers. Nat Rev Mol Cell Biol 2022, 23: 797–816.
Acknowledgments
We thank the members of the Fang lab for their comments and critical reading of the manuscript. We apologize for any omission in citing relevant publications due to the reference limit. The research in the Fang lab is supported by grants from the National Natural Science Foundation of China (32270812 and 31970697) and the Science and Technology Commission of Shanghai Municipality (201409003300, 2019SHZDZX02, and 20490712600).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yue, W., Tang, C.W. & Fang, Y. PIKFYVE Inhibition, A Neuronal “Emetic” for Treating ALS?. Neurosci. Bull. 39, 1738–1740 (2023). https://doi.org/10.1007/s12264-023-01113-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-023-01113-x